While the CYP1B1*3 C4326G mutation has been reported to increase an individual's susceptibility to head and neck cancers [8], [33], Tai et al. reported that this mutation was not associated with susceptibility to either hypopharynx squamous cell carcinoma or laryngeal cancer [28]. This evidence concerns the gene CYP1B1 and squamous cell carcinoma.